NCT04278352View on ClinicalTrials.gov

Mindfulness-Based Relapse Prevention for Opioid and Alcohol Use Disorders

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

August 1, 2023

Study Completion Date

August 1, 2023

Conditions
Opioid-use DisorderOpioid Abuse, in RemissionAlcohol Use DisorderAlcohol Use Disorder, in Remission
Interventions
BEHAVIORAL

Mindfulness Based Relapse Prevention

The intervention is a group skills training program that is delivered once weekly for eight weeks. Content focuses on mindfulness and cognitive-behavioral relapse prevention skills, including psychoeducation, experiential exercises, and between session homework assignments.

Trial Locations (3)

29605

Prisma Health-Upstate Internal Medicine Clinic, Greenville

29607

Phoenix Center, Greenville

29634

Clemson University, Clemson

All Listed Sponsors
collaborator

Prisma Health-Upstate

OTHER

lead

Clemson University

OTHER

NCT04278352 - Mindfulness-Based Relapse Prevention for Opioid and Alcohol Use Disorders | Biotech Hunter | Biotech Hunter